Zhejiang Hisoar Pharmaceutical Co Ltd (002099) — Free Cash Flow Generation Index
Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Free Cash Flow Generation Index of -0.07x as of September 2025. Free cash flow of CN¥-1.04 Million represents 0% of operating cash flow (CN¥15.48 Million). Explore 002099 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang Hisoar Pharmaceutical Co Ltd Free Cash Flow Generation Index (2004–2024)
Historical FCF Generation Index trend for Zhejiang Hisoar Pharmaceutical Co Ltd across 21 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Zhejiang Hisoar Pharmaceutical Co Ltd.
Annual Free Cash Flow Generation for Zhejiang Hisoar Pharmaceutical Co Ltd (2004–2024)
Year-by-year Free Cash Flow Generation Index for Zhejiang Hisoar Pharmaceutical Co Ltd. Check 002099 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.30x | CN¥52.73 Million | CN¥174.83 Million | CN¥122.11 Million | ▼ -17.1% |
| 2023 | 0.36x | CN¥87.46 Million | CN¥240.54 Million | CN¥153.08 Million | ▲ +166.7% |
| 2022 | -0.55x | CN¥-63.33 Million | CN¥116.09 Million | CN¥179.42 Million | ▲ +56.1% |
| 2021 | -1.24x | CN¥-127.20 Million | CN¥102.36 Million | CN¥229.56 Million | ▼ -244.3% |
| 2020 | 0.86x | CN¥459.69 Million | CN¥533.87 Million | CN¥74.18 Million | ▲ +16.7% |
| 2019 | 0.74x | CN¥451.76 Million | CN¥612.40 Million | CN¥160.64 Million | ▲ +9.0% |
| 2018 | 0.68x | CN¥535.67 Million | CN¥791.45 Million | CN¥255.78 Million | ▲ +250.0% |
| 2017 | -0.45x | CN¥-46.32 Million | CN¥102.68 Million | CN¥148.99 Million | ▼ -156.2% |
| 2016 | 0.80x | CN¥505.10 Million | CN¥629.42 Million | CN¥124.31 Million | ▲ +123.7% |
| 2015 | 0.36x | CN¥165.81 Million | CN¥462.16 Million | CN¥296.36 Million | ▲ +205.4% |
| 2014 | 0.12x | CN¥22.50 Million | CN¥191.56 Million | CN¥169.06 Million | ▲ +103.2% |
| 2013 | -3.63x | CN¥-220.94 Million | CN¥60.85 Million | CN¥281.79 Million | ▼ -166.7% |
| 2012 | -1.36x | CN¥-246.06 Million | CN¥180.73 Million | CN¥426.79 Million | ▼ -1.0% |
| 2011 | -1.35x | CN¥-124.91 Million | CN¥92.62 Million | CN¥217.52 Million | ▼ -809.6% |
| 2010 | 0.19x | CN¥34.37 Million | CN¥180.88 Million | CN¥146.51 Million | ▼ -58.3% |
| 2009 | 0.46x | CN¥44.78 Million | CN¥98.38 Million | CN¥53.60 Million | ▲ +123.3% |
| 2008 | -1.95x | CN¥-59.80 Million | CN¥30.61 Million | CN¥90.40 Million | ▼ -62.5% |
| 2007 | -1.20x | CN¥-61.47 Million | CN¥51.14 Million | CN¥112.61 Million | ▼ -82.7% |
| 2006 | -0.66x | CN¥-40.70 Million | CN¥61.88 Million | CN¥102.59 Million | ▲ +37.0% |
| 2005 | -1.04x | CN¥-37.67 Million | CN¥36.07 Million | CN¥73.74 Million | ▼ -24454.1% |
| 2004 | 0.00x | CN¥-180.15K | CN¥42.36 Million | CN¥42.54 Million | — |